Letter: Efficacy and Safety of Carmustine Wafer Implantation After Ventricular Opening in Glioblastomas, Isocitrate Dehydrogenase-Wildtype, in Adults

Neurosurgery. 2024 Jul 1;95(1):e26-e27. doi: 10.1227/neu.0000000000002984. Epub 2024 May 7.

Authors

Pedro Andrade-Andrade^{1

2}, Edgar G Ordóñez-Rubiano^{2

3}, Fernando Hakim¹

Affiliations

¹ Department of Neurosurgery, Fundación Santa Fe de Bogotá, Bogotá , Colombia.
² Faculty of Medicine, Universidad de los Andes, Bogotá , Colombia.
³ Department of Neurosurgery, Fundación Universitaria de Ciencias de la Salud (FUCS) - Hospital de San José, Bogotá , Colombia.

PMID: 38712932
DOI: 10.1227/neu.0000000000002984

No abstract available

Publication types

Letter

MeSH terms

Adult
Antineoplastic Agents, Alkylating* / administration & dosage
Antineoplastic Agents, Alkylating* / adverse effects
Brain Neoplasms* / surgery
Carmustine* / administration & dosage
Carmustine* / adverse effects
Glioblastoma* / drug therapy
Glioblastoma* / surgery
Humans
Isocitrate Dehydrogenase* / genetics
Treatment Outcome

Substances

Isocitrate Dehydrogenase
Carmustine
Antineoplastic Agents, Alkylating